伴侶動物診断の世界市場予測:技術別(免疫診断、臨床生化学、ヘマトロジー、尿分析)、用途別(臨床病理、ウイルス、細菌、寄生虫)、動物別(犬、猫、馬)、エンドユーザー別

◆英語タイトル:Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Hematology, Urine Analysis), Application (Clinical Pathology, Virology, Bacteriology, Parasitology), Animal (Dog, Cat, Horse), End-User - Global Forecast to 2025
◆商品コード:MD 7053
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年3月10日
◆ページ数:283
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は伴侶動物診断の世界市場が2020年18億ドルから2025年30億ドルまで、年平均9.8%成長すると見込んでいます。本調査レポートでは、伴侶動物診断の世界市場を詳細に調査・分析し、イントロダクション、調査手法、プレミアムインサイト、市場概要、技術別(免疫診断、臨床生化学、血液、尿検査、分子診断) 分析、用途別(臨床病理学、細菌学、ウイルス学、寄生虫学、その他)分析、動物別(犬、猫、馬、その他)分析、エンドユーザー別(診断検査室、獣医病院・クリニック、研究機関・大学)分析、地域別分析、競争状況、企業概要などを含めています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・伴侶動物診断の世界市場規模:技術別(免疫診断、臨床生化学、血液、尿検査、分子診断)
・伴侶動物診断の世界市場規模:用途別(臨床病理学、細菌学、ウイルス学、寄生虫学、その他)
・伴侶動物診断の世界市場規模:動物別(犬、猫、馬、その他)
・伴侶動物診断の世界市場規模:エンドユーザー別(診断検査室、獣医病院・クリニック、研究機関・大学)
・伴侶動物診断の世界市場規模:地域別
・競争状況
・企業概要
【レポートの概要】

“The companion, animal diagnostics market, is projected to reach USD 3.0 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 9.8%.” The rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed economies are the major factors that are driving the growth of the global companion animal diagnostics market. The growing demand for rapid tests and portable instruments for point-of-care service is expected to offer potential growth opportunities for market players in the coming years. However, increasing pet care costs are expected to restrain market growth to a certain extent.

“Companion animal diagnostics market for dogs to grow at the highest CAGR during the forecast period”
Based on animal type, the companion animal diagnostics market is segmented into dogs, cats, horses, and other companion animals. The dog’s segment is expected to grow at the highest CAGR during the forecast period majorly due to the growing dog ownership, increasing prevalence of infectious and zoonotic diseases, increasing occurrence of skin allergies in dogs, rising healthcare expenditure for dogs, and the increasing penetration of pet health insurance.

“Home-care testing segment to witness the highest growth during the forecast period”
Based on end-user, the companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals & clinics, home-care settings, and research institutes and universities. The home-care testing segment is estimated to grow at the highest CAGR during the forecast period owing to the advantages of POC/diagnostics in such settings, including ease of use and accurate, real-time results.

“Asia Pacific market to witness the highest growth during the forecast period”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the growing adoption of companion animals, increasing awareness about pet healthcare and zoonotic diseases, and the increasing number of veterinary hospitals and clinics in several APAC countries.

Breakdown of primary participants from the supply side:
• By Company Type – Tier 1–42%, Tier 2–13%, and Tier 3–45%
• By Designation – C Level–17%, Director Level–25%, and Others–58%
• By Region – North America–20%, Europe–28%, Asia Pacific–18%, Latin America- 25%, and the Middle East and Africa–9%

Some of the major players operating in the companion animal diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Heska Corporation (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), Neogen Corporation (US), bioMérieux SA (France), IDvet (France), INDICAL Bioscience GmbH (Germany) [QIAGEN N.V. (Netherlands)], and Randox Laboratories Ltd. (UK).

Research Coverage:
This report analyzes the companion animal diagnostics market and aims at estimating the size and future growth potential of this market based on various segments, namely, technology, application, animal type, end-user, and region. The report also includes a product portfolio matrix of the companion animal diagnostic products available in the market. The competitive leadership mapping provided in this report helps analyze the position of market players as visionary leaders, innovators, dynamic players, and emerging players. A comprehensive competitive analysis of key players in this market, along with their company profiles, product offerings, recent developments, and key growth strategies, has also been provided in this report.

Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a more significant market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global companion animal diagnostics market. The report analyzes this market by technology, application, animal type, end-user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global companion animal diagnostics market.
• Market Development: Comprehensive information on the lucrative emerging markets by technology, application, animal type, end-user, and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global companion animal diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global companion animal diagnostics market.

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 29
1.3 SCOPE OF THE STUDY 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED FOR THE STUDY 31
1.4 CURRENCY 31
1.5 LIMITATIONS 32
1.6 STAKEHOLDERS 32

2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.1.1 SECONDARY SOURCES 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY SOURCES 35
2.1.2.1 primary sources 36
2.1.2.2 key data from primary sources 37
2.2 MARKET SIZE ESTIMATION 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41
2.4 MARKET SHARE ESTIMATION 42
2.5 ASSUMPTIONS FOR THE STUDY 42

3 EXECUTIVE SUMMARY 43

4 PREMIUM INSIGHTS 47
4.1 COMPANION ANIMAL DIAGNOSTICS: MARKET OVERVIEW 47
4.2 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, 2018 48
4.3 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC MIX 50
4.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 50

5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 51
5.3 KEY MARKET DRIVERS 52
5.3.1 GROWTH IN THE COMPANION ANIMAL POPULATION 52
5.3.2 RISING DEMAND FOR PET INSURANCE 53
5.3.3 INCREASING NUMBER OF VETERINARY PRACTITIONERS IN DEVELOPED ECONOMIES 54
5.4 KEY MARKET RESTRAINTS 55
5.4.1 RISING PET CARE COSTS 55
5.5 KEY MARKET OPPORTUNITIES 55
5.5.1 GROWING DEMAND FOR RAPID TESTS & PORTABLE INSTRUMENTS FOR POINT-OF-CARE (POC) DIAGNOSTIC SERVICES 55
5.5.2 USE OF ADVANCED TECHNOLOGIES TO IMPROVE DISEASE DIAGNOSIS ACCURACY IN COMPANION ANIMALS 56
5.6 KEY CHALLENGES 56
5.6.1 LACK OF ANIMAL HEALTHCARE AWARENESS IN EMERGING MARKETS 56
5.6.2 SHORTAGE OF VETERINARIANS IN EMERGING MARKETS 56

6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY 58
6.1 INTRODUCTION 59
6.2 IMMUNODIAGNOSTICS 59
6.2.1 LATERAL FLOW ASSAYS 62
6.2.1.1 Rapid tests 63
6.2.1.1.1 Rising prevalence of infectious diseases to drive the adoption of lateral flow rapid tests 63
6.2.1.2 Strip readers 64
6.2.1.2.1 Lateral flow strip readers are not frequently used by veterinary practitioners 64
6.2.2 ELISA TESTS 65
6.2.2.1 ELISA tests segment to register the highest growth rate during the forecast period 65
6.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 66
6.2.3.1 Growing number of allergy cases in pets to drive market growth 66
6.2.4 IMMUNOASSAY ANALYZERS 67
6.2.4.1 A large number of samples can be loaded into immunoassay analyzers to determine the results of immunoassay tests 67
6.2.5 OTHER IMMUNODIAGNOSTIC PRODUCTS 68
6.3 CLINICAL BIOCHEMISTRY 69
6.3.1 CLINICAL CHEMISTRY ANALYSIS 71
6.3.1.1 Reagents, clips, and cartridges 73
6.3.1.2 Analyzers 74
6.3.1.2.1 Clinical chemistry analyzers have wide applications in veterinary clinics & hospitals, reference laboratories, and research institutes 74
6.3.2 GLUCOSE MONITORING 75
6.3.2.1 Blood glucose strips 76
6.3.2.1.1 Blood glucose strips segment accounted for the largest share of the glucose monitoring market in 2019 76
6.3.2.2 Glucose monitors 77
6.3.2.2.1 The use of glucose monitors helps in making diagnostic and therapeutic decisions in a relatively affordable manner 77
6.3.2.3 Urine glucose strips 78
6.3.2.3.1 Urine glucose strips are used to measure glucose and ketone concentration in urine 78
6.3.3 BLOOD GAS ELECTROLYTE ANALYSIS 79
6.3.3.1 Reagents, clips, and cartridges 81
6.3.3.1.1 Leading market players are providing various cartridges specific for cats, dogs, and equine to measure multiple electrolytes 81
6.3.3.2 Analyzers 82
6.3.3.2.1 Blood gas electrolyte analyzers are used to determine blood pH and the amount of oxygen and carbon dioxide in the blood 82
6.4 HEMATOLOGY 83
6.4.1 CARTRIDGES 84
6.4.1.1 Hematology cartridges are used to measure the hematocrit and hemoglobin levels in animal blood samples 84
6.4.2 ANALYZERS 85
6.4.2.1 Hematology analyzers are used to measure blood cell count and the coagulation time of blood 85
6.5 URINALYSIS 86
6.5.1 CLIPS & CARTRIDGES/PANELS 88
6.5.1.1 Clips and cartridges/panels are used to measure multiple electrolytes and metabolites for the detection of kidney diseases and urinary tract infections 88
6.5.2 URINE ANALYZERS 89
6.5.2.1 Technological advancements to support the growth of this market segment 89
6.5.3 URINE TEST STRIPS 90
6.5.3.1 Urine test strips are used for the qualitative evaluation of urine parameters 90
6.6 MOLECULAR DIAGNOSTICS 91
6.6.1 POLYMERASE CHAIN REACTION TESTS 93
6.6.1.1 PCR testing is a significant tool for the early diagnosis of diseases in dogs, cats, and other companion animals 93
6.6.2 MICROARRAYS 94
6.6.2.1 Increased speed and accuracy of screening and confirmation are driving the use of microarrays in the diagnosis of various conditions in companion animals 94
6.6.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 95
6.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES 96

7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION 97
7.1 INTRODUCTION 98
7.2 CLINICAL PATHOLOGY 98
7.2.1 CLINICAL PATHOLOGY IS THE LARGEST APPLICATION SEGMENT IN THE COMPANION ANIMAL DIAGNOSTICS MARKET 98
7.3 BACTERIOLOGY 99
7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 99
7.4 VIROLOGY 100
7.4.1 RISING NUMBER OF VIRAL OUTBREAKS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 100
7.5 PARASITOLOGY 101
7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 101
7.6 OTHER APPLICATIONS 102

8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE 104
8.1 INTRODUCTION 105
8.2 DOGS 106
8.2.1 RISING PET DOG POPULATION TO DRIVE MARKET GROWTH 106
8.3 CATS 107
8.3.1 GROWING RESEARCH INTO FELINE HEALTHCARE AND WELLBEING SUPPORTS MARKET GROWTH 107
8.4 HORSES 109
8.4.1 GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH 109
8.5 OTHER COMPANION ANIMALS 110

9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER 112
9.1 INTRODUCTION 113
9.2 DIAGNOSTIC LABORATORIES 114
9.2.1 DIAGNOSTIC LABORATORIES RECEIVE A LARGE VOLUME OF SAMPLES FROM VETERINARY PRACTICES 114
9.3 VETERINARY HOSPITALS & CLINICS 115
9.3.1 HOSPITALS & CLINICS ARE THE FIRST POINTS OF CONTACT FOR PET OWNERS 115
9.3.2 HOME-CARE SETTINGS 116
9.3.3 IMPROVED CARE AND COST CONTROL DRIVES THE ADOPTION OF POC DIAGNOSTICS WITHIN HOME CARE SETTINGS 116
9.4 RESEARCH INSTITUTES & UNIVERSITIES 117
9.4.1 THE NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS HAVE INCREASED IN RECENT YEARS 117

10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION 119
10.1 INTRODUCTION 120
10.2 NORTH AMERICA 121
10.2.1 US 127
10.2.1.1 The US dominates the companion animal diagnostics market in North America 127
10.2.2 CANADA 131
10.2.2.1 Awareness of pet health has risen in Canada 131
10.3 EUROPE 136
10.3.1 GERMANY 142
10.3.1.1 Germany is the largest market for companion animal diagnostics in Europe 142
10.3.2 UK 148
10.3.2.1 Stable increase in pet ownership and preventive measures against animal diseases promoted by regulatory authorities to drive the UK market 148
10.3.3 FRANCE 153
10.3.3.1 Technological expertise and innovations attract market players to compete in the companion animal diagnostics market in France 153
10.3.4 ITALY 158
10.3.4.1 Increased pet adoption, along with better availability of pet products through large-scale outlets, supports market growth in Italy 158
10.3.5 SPAIN 162
10.3.5.1 Rising animal health expenditure and the growing number of veterinary facilities to drive the growth of this market 162
10.3.6 BENELUX 166
10.3.7 REST OF EUROPE 171
10.4 ASIA PACIFIC 175
10.4.1 CHINA 181
10.4.1.1 China dominates the Asia Pacific companion animal diagnostics market 181
10.4.2 JAPAN 185
10.4.2.1 Rising demand for imported pet breeds is expected to drive the overall growth of this market 185
10.4.3 INDIA 189
10.4.3.1 India is an untapped market with large growth potential in companion animal diagnostics 189
10.4.4 AUSTRALIA 193
10.4.5 REST OF APAC 198
10.5 LATIN AMERICA 201
10.5.1 BRAZIL 206
10.5.1.1 Brazil has the third-largest pet population in the world 206
10.5.2 MEXICO 210
10.5.2.1 Mexico is the second-largest pet care market in Latin America 210
10.5.3 REST OF LATIN AMERICA 214
10.6 MIDDLE EAST 219
10.6.1 RELUCTANCE TO SPEND ON PET HEALTH HAS SLOWED THE PACE OF MARKET GROWTH 219
10.7 AFRICA 223
10.7.1 DISEASES IN IMPORTED BREEDS TO DRIVE THE GROWTH OF THE MARKET 223

11 COMPETITIVE LANDSCAPE 228
11.1 INTRODUCTION 228
11.2 GROWTH STRATEGY MATRIX 229
11.3 MARKET SHARE ANALYSIS 229
11.4 COMPETITIVE SITUATION AND TRENDS 230
11.4.1 PRODUCT LAUNCHES 230
11.4.2 ACQUISITIONS 231
11.4.3 PARTNERSHIPS 232
11.4.4 EXPANSIONS 232
11.5 COMPETITIVE LEADERSHIP MAPPING 233
11.5.1 VISIONARY LEADERS 233
11.5.2 INNOVATORS 233
11.5.3 DYNAMIC DIFFERENTIATORS 233
11.5.4 EMERGING COMPANIES 234

12 COMPANY PROFILES 235
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 IDEXX LABORATORIES, INC. 235
12.2 ZOETIS INC. 239
12.3 HESKA CORPORATION 243
12.4 THERMO FISHER SCIENTIFIC INC. 247
12.5 VIRBAC 250
12.6 NEOGEN CORPORATION 253
12.7 BIOMÉRIEUX SA 255
12.8 INDICAL BIOSCIENCE GMBH (QIAGEN N.V.) 257
12.9 FUJIFILM HOLDINGS CORPORATION 259
12.10 IDVET 261
12.11 RANDOX LABORATORIES, LTD. 262
12.12 MINDRAY MEDICAL INTERNATIONAL LIMITED (A PART OF EXCELSIOR UNION LIMITED) 264
12.13 SKYLA 265
12.14 BIONOTE INC. 266
12.15 SCIL ANIMAL CARE COMPANY GMBH 268
12.16 OTHER EMERGING PLAYERS 269
12.16.1 URIT MEDICAL ELECTRONIC CO., LTD. 269
12.16.2 EUROLYSER DIAGNOSTICA GMBH 269
12.16.3 NOVA BIOMEDICAL 270
12.16.4 FASSISI GMBH 271
12.16.5 SWISSAVANS AG 272
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies

13 APPENDIX 273
13.1 INSIGHTS OF INDUSTRY EXPERTS 273
13.2 DISCUSSION GUIDE 274
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 281
13.4 AVAILABLE CUSTOMIZATIONS 283
13.5 RELATED REPORTS 283
13.6 AUTHOR DETAILS 284



LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 33
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 38
FIGURE 3 BOTTOM-UP APPROACH: REVENUE SHARE ANALYSIS 39
FIGURE 4 ILLUSTRATIVE EXAMPLE: BUILDING THE COMPANION ANIMAL DIAGNOSTICS MARKET BASED ON COMPANY REVENUE ESTIMATION 39
FIGURE 5 DATA TRIANGULATION METHODOLOGY 41
FIGURE 6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 43
FIGURE 7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 44
FIGURE 8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020 VS. 2025 (USD MILLION) 44
FIGURE 9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 45
FIGURE 10 GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET 46
FIGURE 11 GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 47
FIGURE 12 CHINA HOLDS THE LARGEST SHARE OF THE APAC COMPANION ANIMAL DIAGNOSTICS MARKET IN 2019 48
FIGURE 13 CHINA AND INDIA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 49
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE COMPANION ANIMAL DIAGNOSTICS MARKET BY 2025 50
FIGURE 15 DEVELOPING MARKETS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 50
FIGURE 16 DEVELOPED COUNTRIES: PET POPULATION & PET OWNERSHIP 52
FIGURE 17 US: PET INDUSTRY EXPENDITURE 53
FIGURE 18 DEVELOPED ECONOMIES: NUMBER OF VETERINARY PROFESSIONALS
(2016 VS 2018) 54
FIGURE 19 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY (2016 VS 2018) 57
FIGURE 20 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE 105
FIGURE 21 GEOGRAPHIC SNAPSHOT (2019): US ACCOUNTED FOR THE LARGEST SHARE OF THE COMPANION ANIMAL DIAGNOSTICS MARKET 121
FIGURE 22 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 122
FIGURE 23 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 137
FIGURE 24 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 176
FIGURE 25 KEY DEVELOPMENTS IN THE COMPANION ANIMAL DIAGNOSTICS MARKET BETWEEN JANUARY 2017 AND FEBRUARY 2020 228
FIGURE 26 COMPANION ANIMAL DIAGNOSTICS MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2019 229
FIGURE 27 COMPANION DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 234
FIGURE 28 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2019) 235
FIGURE 29 ZOETIS INC.: COMPANY SNAPSHOT (2018) 239
FIGURE 30 HESKA CORPORATION: COMPANY SNAPSHOT (2018) 243
FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2018) 247
FIGURE 32 VIRBAC: COMPANY SNAPSHOT (2018) 250
FIGURE 33 NEOGEN CORPORATION: COMPANY SNAPSHOT (2019) 253
FIGURE 34 BIOMERIEUX SA: COMPANY SNAPSHOT (2018) 255
FIGURE 35 QIAGEN N.V.: COMPANY SNAPSHOT (2018) 257
FIGURE 36 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2018) 259


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[伴侶動物診断の世界市場予測:技術別(免疫診断、臨床生化学、ヘマトロジー、尿分析)、用途別(臨床病理、ウイルス、細菌、寄生虫)、動物別(犬、猫、馬)、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆